Becton, Dickinson Profit Margins 2006-2018 | BDX

Current and historical gross, operating and net profit margins for Becton, Dickinson (BDX) over the last 10 years. The current net profit margin for Becton, Dickinson (BDX) as of March 31, 2018 is -0.46%.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.027B $12.093B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
Align Technology (ALGN) United States $29.698B 87.80
McKesson (MCK) United States $27.155B 10.65
AmerisourceBergen (ABC) United States $19.083B 13.89
Laboratory Of America Holdings (LH) United States $18.836B 18.19
Cardinal Health (CAH) United States $15.525B 9.80
Cooper (COO) United States $12.083B 22.49
Henry Schein (HSIC) United States $11.501B 20.37
DENTSPLY SIRONA (XRAY) United States $10.394B 17.44
West Pharmaceutical Services (WST) United States $7.275B 40.52
Merit Medical Systems (MMSI) United States $2.856B 42.92
Patterson (PDCO) United States $2.155B 13.54
CONMED (CNMD) United States $2.075B 36.09
STAAR Surgical (STAA) United States $1.411B 484.29
Atrion (ATRI) United States $1.141B 32.60
Invacare (IVC) United States $0.701B 0.00
Endologix (ELGX) United States $0.453B 0.00
Antares Pharma (ATRS) United States $0.422B 0.00
Lifevantage (LFVN) United States $0.142B 29.41
Aceto (ACET) United States $0.105B 4.26
Milestone Scientific (MLSS) United States $0.030B 0.00
Pro-Dex (PDEX) United States $0.029B 12.93
Retractable Technologies (RVP) United States $0.028B 0.00
Biolase (BIOL) United States $0.027B 0.00